Previous Article | Next Article ![]()
Infect. Immun., 08 1997, 3024-3031, Vol 65, No. 8
A Egan, M Waterfall, M Pinder, A Holder and E Riley
We have investigated the relationship between cellular and humoral immune
responses to defined epitopes of the C terminus of merozoite surface
protein 1 (MSP-1) of the human malaria parasite, Plasmodium falciparum, in
immune blood donors. Sera from almost all donors contained antibodies to
the 33-kDa processing product of the MAD20 allele of MSP-1 (MSP-1(33)), but
these antibodies did not cross-react with the equivalent sequence of the
Wellcome allele. In contrast, T- cell responses to MSP-1(33) are directed
towards epitopes that are conserved between the two allelic families. Only
50% of adult blood donors possessed antibodies which recognized the 19-kDa
processing product of MSP-1 (MSP-1(19)). These antibodies predominantly
recognized conserved epitopes involving both of the constituent epidermal
growth factor-like domains of MSP-1(19). T-cell responses were found in
only 26% (for recombinant proteins) or 44% (for synthetic peptides) of
donors and were directed mainly at dimorphic sequences of the protein.
There was no obvious association, at an individual level, between the
presence of antibodies and the detection of T-cell proliferative or gamma
interferon responses, suggesting that the T cells identified in this manner
are not providing significant levels of help to B cells. T- cell responses
to reduced recombinant proteins and linear peptides were more prevalent
than responses to disulfide-bonded proteins, suggesting that the complex
disulfide-bonded structure of native MSP-1(19) may inhibit antigen
processing or presentation.
Copyright © 1997, American Society for Microbiology
Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T- cell recognition of polypeptides with numerous disulfide bonds
Institute of Cell, Animal and Population Biology, Division of Biological Sciences, University of Edinburgh, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|